Atorvastatin Calcium Tablet
Product Images NDC 75834-256

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 75834-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-calcium-10-90 (Atorvastatin Calcium 10 90)

Atorvastatin Calcium Tablets, USP 10 mg oral tablets in a 90-tablet package by Nivagen Pharmaceuticals, Inc. The label includes NDC 75834-255-90, storage instructions at 20°C-25°C, and manufacturer information for Umedica Laboratories Pvt. Ltd. in Gujarat, India. It notes child-resistant packaging and prescription-only status.*

FDA Label Image

Atorvastatin-calcium-20-1000 (Atorvastatin Calcium 20 1000)

Atorvastatin Calcium Tablets USP 20 mg label from Nivagen Pharmaceuticals, Inc. The label includes the NDC 75834-256-01 and states 1000 tablets. It lists storage instructions at controlled room temperature 20°C-25°C and manufacturer details for Nivagen Pharmaceuticals, Inc. in Sacramento, CA and Umedica Laboratories Pvt. Ltd. in Gujarat, India.*

FDA Label Image

Atorvastatin-calcium-40-500 (Atorvastatin Calcium 40 500)

Label of Atorvastatin Calcium Tablets USP 40 mg by Nivagen Pharmaceuticals, Inc. The tablet count is 500. The label includes storage instructions, dosage directions to see package insert, and manufacturer details from Umedica Laboratories Pvt. Ltd., India. The label shows the NDC number 75834-257-50, barcode, and states Rx only.*

FDA Label Image

Atorvastatin-calcium-80-2000 (Atorvastatin Calcium 80 2000)

Label for Atorvastatin Calcium Tablets USP, 80 mg strength, produced by Nivagen Pharmaceuticals, Inc. The label states a count of 2000 tablets, with storage instructions to keep at controlled room temperature (20°C-25°C). It includes the national drug code (NDC 75834-258-02), manufacturer details for Umedica Laboratories Pvt. Ltd. in India, and cautions to keep out of reach of children and to dispense in a tight container.*

FDA Label Image

Atorvastatin-calcium (Atorvastatin Calcium)

Chemical structure of atorvastatin calcium, showing the detailed molecular arrangement including aromatic rings, hydroxyl groups, fluorophenyl group, and calcium ion complexation with water molecules.*

FDA Label Image

Figure-1-atorvastatin-calcium (Figure 1 Atorvastatin Calcium)

A line graph depicting cumulative incidence (%) of disease death over 3.5 years in the ASCOT-LLA study, comparing Atorvastatin and placebo groups. The graph shows lower incidence for Atorvastatin, with a hazard ratio (HR) of 0.64 (0.50-0.83) and p-value of 0.0005 indicated.*

FDA Label Image

Figure-2-atorvastatin-calcium (Figure 2 Atorvastatin Calcium)

A Kaplan-Meier curve showing cumulative hazard percentage over time in years for Atorvastatin versus placebo. The graph depicts time to first primary endpoint through four years of follow-up, illustrating a lower cumulative hazard for Atorvastatin compared to placebo over five years.*

FDA Label Image

Figure-3-atorvastatin-calcium (Figure 3 Atorvastatin Calcium)

A line graph comparing the percentage of subjects experiencing an event over time between Atorvastatin 10 mg and Atorvastatin 80 mg groups. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with a confidence interval (0.69-0.89) and a p-value of 0.0002, indicating statistical analysis results.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.